Ticker · PCX

XLV · State Street Health Care Select Sector SPDR ETF

Healthcare · Healthcare Sector ETF

State Street Health Care Select Sector SPDR ETF

PCX · Healthcare / Healthcare Sector ETF
All sectors →
XLV
$161.41
+1.17%
7-day move
day$160.33 $162.2452-wk$127.96 $165.61avg vol10.4M / 3Mcap$40.6B
Plate I.

The Past Year, in One Line

$140$150$160$170$180202120222023202420252026$161.41XLV
The Valuation
P/E (forward)
P/E (trailing)29.0
EPS (forward)
EPS (trailing)
PEG
Dividend1.60%
The Risk
Beta
Short % float
Float
Shares out197.4M
Avg vol (3M)10.4M
52w range$127.96 → $165.61
The Analyst Tape
No sell-side analyst coverage on file. ETFs and many small-caps skip the desk treatment.
At a Glance
$40.6B
market cap (USD)
exchangePCX
sectorHealthcare
industryHealthcare Sector ETF
market cap$40.6B

The Briefs

live, polled every 60 seconds · Alpaca / Benzinga
No recent headlines for XLV in the last 7 days.

Word on the Street

StockTwits public feed · self-tagged bull/bear
No recent StockTwits posts for XLV.

Indicators That Mention XLV

8 of our 658 catalog map to XLV
SP-3079
XLV Healthcare ETF
Healthcare SPDR — pharma + biotech + insurers + devices. Broader than UNH alone.
49%
49%
50%
49%
50%
51%
Still works on fresh data
r=-0.03
SP-1251
AbbVie
Pharma mega-cap. Production tell via epa_abbv_waste.
49%
49%
49%
49%
52%
48%
Still works on fresh data
r=-0.10
SP-1365
Pfizer
Big pharma. Vaccine + small-molecule production via epa_pfe_waste.
49%
49%
50%
49%
49%
49%
Still works on fresh data
r=-0.03
SP-1458
UnitedHealth Group
Biggest US health insurer. Pricing power = consumer cost forecast.
49%
49%
49%
49%
50%
51%
Still works on fresh data
r=-0.04
SP-3601
ABBV TRI Chemical Releases
Annual chemical releases from AbbVie US plants. Pharma batch chemistry.
50%
50%
50%
50%
50%
50%
Too new to retest
r=0.00
SP-3174
AbbVie Hazardous Waste Tonnage
Monthly hazardous waste from AbbVie US plants. Drug batch chemistry, mixed-clean signal.
50%
50%
50%
50%
50%
50%
Not yet retested on fresh data
r=0.00
SP-3646
LLY TRI Chemical Releases
Annual chemical releases from Eli Lilly US plants. Pharma production (incl. GLP-1).
50%
50%
50%
50%
50%
50%
Too new to retest
r=0.00
SP-3667
MRK TRI Chemical Releases
Annual chemical releases from Merck US plants. Pharma + vaccine production.
50%
50%
50%
50%
50%
50%
Too new to retest
r=0.00
Standard Poorly Disclaimer
We tested 658 indicators against six horizons. By chance alone, ~197 of these correlations should look "significant." Walk-forward out-of-sample is the only thing we trust.

Other Players in the Pipeline

Healthcare · by market cap · 7-day move
Metadata last refreshed 2026-07-14T04:17:29.718026+00:00 via yfinance. Price figures are end-of-day; intraday quotes are not surfaced on the free tier. We don't provide investment advice — see methodology for what we do and don't claim.

Voices on XLVcommentarylive

Curated commentary (Kobeissi, Doomberg, Lyn Alden, QuoteTheRaven, Pomp, ZeroHedge) mentioning XLV. Opinion, not wire.
No recent commentary mentioning XLV in the last 7 days.
Analyst · previewYou're seeing the public read on XLV. Analyst unlocks every pundit call on XLV with open P&L + alerts when a new position opens + the full related-indicator firing history. Trader adds intraday quotes + cross-asset co-fire scoring with XLV as the target + the API / MCP feed.Compare tiers →